Clinical trial
Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver…
NCT00039078 · Allan Tsung, Other · Withdrawn
Key facts
| NCT number | NCT00039078 |
|---|---|
| Title | Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery |
| Official title | The Use of TheraSphere® for the Treatment of Unresectable Hepatocellular Carcinoma |
| Lead sponsor | Allan Tsung, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Radiation |
| Interventions | yttrium Y 90 glass microspheres |
| Enrollment | 0 |
| Start date | Aug 1, 2000 |
| Primary completion | Aug 1, 2000 |
| Completion | Aug 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: